Stock Price Quote

GANGA PHARMACEUTICALS LTD.

NSE : NABSE : 539680ISIN CODE : INE615T01017Industry : Pharmaceuticals & DrugsHouse : Private
BSE24.410 (0 %)
PREV CLOSE ( ) 24.41
OPEN PRICE ( ) 24.41
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 8000
TODAY'S LOW / HIGH ( )24.41 24.41
52 WK LOW / HIGH ( ) 7.528.49
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-09 1989
Management Info
Sanjay Vyankatesh Kulkarni - Chairman Bharat Brijmohan Sharma - Managing Director
Registered Office

Address Gangatat, Dhanvantri Marg,Gopchar Pada,Virar East,
Palghar,
Maharashtra-401305

Phone 08452049222 / 09967840111

Email gplvirar@gmail.com / gangapharmaltd@gmail.com

Website www.ayurvedganga.com

Registrars Details
K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.)
Karvy Selenium Tower B, Plot 31-32,Gachibowli,Financial District,Nanakramguda,Hyderabad
Listing : BSE

NEWS

07Feb Ganga Pharmaceuticals informs about di
Ganga Pharmaceuticals has informed that it has received the disclosure u..
27Jan Ganga Pharmaceuticals informs about di
Ganga Pharmaceuticals has informed that it enclosed the disclosure under..
13Dec Ganga Pharmaceuticals informs about pr
Ganga Pharmaceuticals has informed that it enclosed newspaper Advertisem..
12Dec Ganga Pharmaceuticals informs about EGM
Ganga Pharmaceuticals has informed that an Extra-Ordinary General Meetin..
03Oct Ganga Pharmaceuticals informs about di
Ganga Pharmaceuticals has informed that it enclosed the disclosure under..

Financials

in Millions
QTR Mar 18 ANNUAL 23
Net Profit0.850.399999999999999
Gross Profit 1.13 0.539999999999999
Operating Profit 2.853.04
Net Sales 19.4625.86

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE)
peergroup  27000.00 (0.94%)
M.Cap ( in Cr)56866.43
Dr. Reddy's Lab (BSE)
peergroup  6179.15 (2.18%)
M.Cap ( in Cr)102676.64
Divi's Lab (BSE)
peergroup  3453.00 (2.62%)
M.Cap ( in Cr)91087.58
RPG Life Sciences (BSE)
peergroup  1531.70 (4.02%)
M.Cap ( in Cr)2524.02
Caplin Point Lab (BSE)
peergroup  1319.00 (4.69%)
M.Cap ( in Cr)9765.35

Shareholding Pattern

PROMOTERS 56.02%
NON-INSTITUTION 43.98%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Ganga Pharmaceuticals Ltd.

Ganga Pharmaceuticals Ltd. was incorporated in the year 1989. Its today's share price is 24.41. Its current market capitalisation stands at Rs 11.81 Cr. In the latest quarter, company has reported Gross Sales of Rs. 25.86 Cr and Total Income of Rs.28.85 Cr. The company's management includes Priti Bhaiya, Sachin Chandrakant Chavan, Chetan Bhikhubhai Patel, Srijana Bharat Sharma, Bharat Brijmohan Sharma, Sanjay Vyankatesh Kulkarni.

It is listed on the BSE with a BSE Code of 539680 , NSE with an NSE Symbol of and ISIN of INE615T01017. It's Registered office is at Gangatat, Dhanvantri Marg,Gopchar Pada,Virar EastPalghar-401305, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Amarnath Sharma & Co, Anil Bansal & Associates, Anil Bansal & Co, Banka & Banka

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.